Expand ABOS Menu
ABOS MENU

ABOS Latest Press Releases

-- August 12, 2026 --

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- August 5, 2026 --

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026 Globe Newswire 4:00 PM

-- July 15, 2026 --

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery (EBD ) Program Data and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference (AAIC) 2026 Globe Newswire 7:30 AM

-- July 7, 2026 --

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery (EBD ) Technology and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference (AAIC) 2026 Globe Newswire 7:30 AM

-- June 17, 2026 --

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo Technology Platform Business Wire 12:30 PM

-- June 16, 2026 --

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery (EBD ) Development Candidates for the Treatment of Alzheimer's Disease Globe Newswire 7:30 AM

-- May 12, 2026 --

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- May 7, 2026 --

Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference Globe Newswire 4:00 PM

-- May 5, 2026 --

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 Globe Newswire 4:00 PM
Market Data Delayed 15 Minutes